Awarded by the Royal College of Radiologists of the United Kingdom for his BCRM presentation, Christopher Nutting is a prestigious Oncologist specialized in the areas of Radiotherapy and Chemotherapy. He has an extensive professional background of more than 30 years, where he has been part of reference health institutions such as the Royal Marsden Hospital or the Institute of Cancer Research in London.  

In his firm commitment to optimize the quality of life of his patients, he contributed to the installation of Magnetic Resonance Imaging machines for the first time in Great Britain, incorporating a scanner and Linear Accelerator to locate tumors with greater precision. In addition, his clinical research has contributed to the development of several advances in the oncological field. His most outstanding contribution is Intensity-Modulated Radiation Therapy, a technique that improves the efficacy of cancer treatments by directing radiation to a specific target so as not to damage nearby healthy tissue.  

In turn, he has performed more than 350 clinical studies and scientific publications that have facilitated the understanding of malignant tumors. For example, its "PARSPOT" trial provided relevant clinical data on the efficacy of Linear Accelerator Intensity Modulated Radiation Therapy in terms of local carcinoma control and patient survival. Thanks to these results, the UK Department of Health established practices to optimize both the accuracy and effectiveness of Radiotherapy in the treatment of Head and Neck Cancer. 

He is a regular speaker at Scientific Congresses, where he shares his solid knowledge in subjects such as Radiotherapy Technology or innovative therapies for the approach of people with Dysphagia. In this way, he helps medical professionals to stay at the forefront of advances in these fields in order to provide excellent services.

• Medical Director and Oncology Consultant at The Royal Marsden Hospital in London, United Kingdom
• Chairman of the Oncology Section at the Royal Society of Medicine, London, United Kingdom
• Clinical Head of Head and Neck Cancer at the Department of Health and Social Care, United Kingdom
• Consultant Oncologist at The Harley Street Clinic in London, United Kingdom
• Chairman of the National Cancer Research Institute in London, United Kingdom
• President of the Association of British Oncology in London, United Kingdom
• Senior Research Fellow at the National Institute for Health and Care Research, United Kingdom
• PhD in Medicine and Cellular Pathology from the University of London
• Member of:
  
  • UK College of Physicians
  • UK College of Radiologists